Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (321-330 of 785) with videos related to

Pageof 79
Sort By:
MMW Fortschritte Der Medizin|April 4, 2024
[InspeCKD - Analysis of the use of diagnostics in patients at high risk for chronic kidney disease in German general practitioner (GP) practices]Christoph Wanner, Elke Schaeffner, Thomas Frese, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 10, 2019
Choice of endpoint in kidney outcome trials: considerations from the EMPA-REG OUTCOME® trialVlado Perkovic, Audrey Koitka-Weber, Mark E Cooper, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 31, 2020
Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarctionMarco Trevisan, Edouard L Fu, Karolina Szummer, et al.
Journal of Nephrology|May 14, 2022
Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims databaseChristoph Wanner, Johannes Schuchhardt, Chris Bauer, et al.
Nature Reviews. Disease Primers|November 24, 2017
Chronic kidney diseasePaola Romagnani, Giuseppe Remuzzi, Richard Glassock, et al.
Nephron. Physiology|July 2, 2005
L-Arginine does not affect renal morphology and cell survival in ischemic acute renal failure in ratsUlrike Raff, Reinhard Schneider, Stepan Gambaryan, et al.
Kidney International|August 20, 2010
National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce eventsGeorge Bakris, Joseph Vassalotti, Eberhard Ritz, et al.
BMC Neurology|May 28, 2013
Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control studyNurcan Üçeyler, Ann-Kathrin Kahn, Daniela Kramer, et al.
Innere Medizin (Heidelberg, Germany)|August 5, 2025
[InspeCKD: an analysis of the prevalence, diagnosis, and treatment of chronic kidney disease : Data from at-risk patients in German primary care]Christoph Wanner, Elke Schaeffner, Thomas Frese, et al.
International Journal of Cardiology|April 6, 2011
MR-based analysis of regional cardiac function in relation to cellular integrity in Fabry diseaseSabrina Koeppe, Henning Neubauer, Frank Breunig, et al.
Pageof 79

Showing results (321-330 of 785) with videos related to

Sort By:
Pageof 79
MMW Fortschritte Der Medizin|April 4, 2024
[InspeCKD - Analysis of the use of diagnostics in patients at high risk for chronic kidney disease in German general practitioner (GP) practices]Christoph Wanner, Elke Schaeffner, Thomas Frese, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 10, 2019
Choice of endpoint in kidney outcome trials: considerations from the EMPA-REG OUTCOME® trialVlado Perkovic, Audrey Koitka-Weber, Mark E Cooper, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 31, 2020
Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarctionMarco Trevisan, Edouard L Fu, Karolina Szummer, et al.
Journal of Nephrology|May 14, 2022
Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims databaseChristoph Wanner, Johannes Schuchhardt, Chris Bauer, et al.
Nature Reviews. Disease Primers|November 24, 2017
Chronic kidney diseasePaola Romagnani, Giuseppe Remuzzi, Richard Glassock, et al.
Nephron. Physiology|July 2, 2005
L-Arginine does not affect renal morphology and cell survival in ischemic acute renal failure in ratsUlrike Raff, Reinhard Schneider, Stepan Gambaryan, et al.
Kidney International|August 20, 2010
National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce eventsGeorge Bakris, Joseph Vassalotti, Eberhard Ritz, et al.
BMC Neurology|May 28, 2013
Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control studyNurcan Üçeyler, Ann-Kathrin Kahn, Daniela Kramer, et al.
Innere Medizin (Heidelberg, Germany)|August 5, 2025
[InspeCKD: an analysis of the prevalence, diagnosis, and treatment of chronic kidney disease : Data from at-risk patients in German primary care]Christoph Wanner, Elke Schaeffner, Thomas Frese, et al.
International Journal of Cardiology|April 6, 2011
MR-based analysis of regional cardiac function in relation to cellular integrity in Fabry diseaseSabrina Koeppe, Henning Neubauer, Frank Breunig, et al.
Pageof 79